EraCal

About:

EraCal Therapeutics develops drugs to treat different diseases.

Top Investors: Venture Kick, redalpine, Bernina BioInvest, Life Sciences Fund

Description:

EraCal Therapeutics is a Swiss biotech company committed to cutting-edge science and medicine. EraCal develops drugs to treat different diseases.

Total Funding Amount:

1.13M CHF

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Zürich, Zurich, Switzerland

Founded Date:

2017-01-01

Founders:

J. Jordi

Number of Employees:

1-10

Last Funding Date:

2019-10-18

IPO Status:

Private

Industries: